Last update: June 10, 2018
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
This is one of the alkaloids from the Vinca minor plant with vasodilatory properties. Indicated without sufficient evidence to increase cerebral circulation.
Administered orally 3 times a day.
It can trigger serious cardiac arrhythmias (Fauchier 1993, Dany 1981).
It has very few bibliographical references. It is classified as having low therapeutic efficacy (Canary Islands Health Service 2011, INSALUD 2001).
Since the last update date we have not found published data on its excretion in breastmilk.
Until there is more published data about this drug in relation to breastfeeding, safer alternatives may be preferred, especially during the neonatal period and in the case of prematurity.
It is a non-essential medication and even more so during breastfeeding. If you have to use it, you can minimize the risk by waiting to breastfeed, if possible, about 4 hours after the medication is taken.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM